Sagent launches ciprofloxacin
SCHAUMBURG -- Sagent Pharmaceuticals Inc., a privately-held specialty pharmaceutical company, Wednesday launched ciprofloxacin injection, a synthetic broad spectrum anti-microbial agent for intravenous use for bacterial infections. It will be available immediately. According to IMS data, sales of injectable ciprofloxacin in the United States in 2006 were approximately $60 million. Ciprofloxacin is the third product introduced by Sagent.
Article Comments
Guidelines: Keep it civil and on topic; no profanity, vulgarity, slurs or personal attacks. People who harass others or joke about tragedies will be blocked.
If a comment violates these standards or our terms of service, click the "flag" link in the lower-right corner of the comment box. To find our more, read our FAQ.